Construction Cost
-
Vermeulens Releases Q4-2019 Market Outlook
3-31-2020Vermeulens has released its market outlook report for the fourth quarter of 2019. Key points include:
-
Foghorn Therapeutics Breaks Ground on Kendall Square Headquarters
2-2-2020Foghorn Therapeutics broke ground in January of 2020 on its 60,000-sf headquarters in Cambridge, Mass. Located in Kendall Square, the facility will provide chemistry and biology labs, open offices, conference rooms, huddle rooms, and an employee café.
-
Vermeulens Releases Q3-2019 Market Outlook
12-16-2019Vermeulens has released its market outlook report for the third quarter of 2019. Key points include:
-
Michigan State University and Health Innovation Partners Break Ground on Medical Innovation Building
12-6-2019Michigan State University broke ground on the $85 million Doug Meijer Innovation Building in Grand Rapids in November of 2019.
-
University of Delaware Plans Fintech Building
12-5-2019The University of Delaware is planning to construct a $38 million fintech building in Newark.
-
Vermeulens Releases Q2-2019 Market Outlook
9-30-2019Vermeulens has released its market outlook report for the second quarter of 2019. Key points include:
-
Amgen Breaks Ground on Biomanufacturing Facility
9-3-2019Amgen broke ground in late July of 2019 on a $200 million biomanufacturing center in West Greenwich, R.I.
-
Vermeulens Releases Q1-2019 Market Outlook
7-6-2019Vermeulens has released its market outlook report for the first quarter of 2019. Key points include:
-
Southwestern College Dedicates Math and Science Building
7-5-2019Southwestern College dedicated the $85.6 million Math and Science Building in June of 2019 in Chula Vista, Calif.
-
The Future of Xenotransplantation—Thinking Outside the Walls
6-19-2019With demand for human donor organs historically and increasingly outpacing the available, viable supply, researchers and physicians have looked for decades at xenotransplantation—cross-species transplantation—as a possible vehicle to overcome the problem. The traditional approach to xenotransplantation, however, is an “impediment to moving transplantation forward,” asserts Karl Kraebber, director of xenotransplantation operations at the University of Alabama at Birmingham School of Medicine. His team believes the solution isn’t in expensive and time-consuming renovation of existing buildings. “Our more novel approach is for flexible, modular spaces, to be used for small pilot trials and then scaled up once we have partnership with our governing agencies,” he says. “We’ll take ‘fast and good’ over ‘slow and perfect’ every time. It doesn’t mean we’re cutting corners.”
